Gliadin stimulates human monocytes to production of IL-8 and TNF-alpha through a mechanism involving NF-kappaB
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
15280021
DOI
10.1016/j.febslet.2004.06.057
PII: S0014579304008099
Knihovny.cz E-zdroje
- MeSH
- buněčné linie MeSH
- ELISA MeSH
- gliadin farmakologie MeSH
- interleukin-8 biosyntéza MeSH
- kinetika MeSH
- lidé MeSH
- monocyty účinky léků imunologie fyziologie MeSH
- NF-kappa B metabolismus MeSH
- ovalbumin farmakologie MeSH
- peptidové fragmenty farmakologie MeSH
- proteiny ze sójových bobů farmakologie MeSH
- pšenice MeSH
- sekvence aminokyselin MeSH
- TNF-alfa biosyntéza MeSH
- U937 buňky MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- gliadin MeSH
- interleukin-8 MeSH
- NF-kappa B MeSH
- ovalbumin MeSH
- peptidové fragmenty MeSH
- proteiny ze sójových bobů MeSH
- TNF-alfa MeSH
Wheat gliadin is the triggering agent in coeliac disease. In this study, we documented that proteolytic fragments of gliadin, in contrast to other food antigens, induced interleukin (IL)-8 and tumour necrosis factor-alpha (TNF-alpha) production and significantly increased interferon (IFN)-gamma-induced cytokine secretion in human monocytic line THP-1 cells. Stimulation with gliadin resulted in elevated phosphorylation of the IkappaBalpha molecule and increased NF-kappaB/DNA binding activity that was inhibited by sulfasalazine, l-1-tosylamido-2-phenylethyl chloromethyl ketone and pyrrolidine dithiocarbamate (PDTC). The activation pathway was shown to be independent of the CD14 molecule. Less mature U-937 monocytes responded to gliadin stimulation by low IL-8 secretion, TNF-alpha production was not detectable. We propose that gliadin-induced activation of monocytes/macrophages can participate in mechanisms leading to the impairment of intestinal mucosa in coeliac patients.
Citace poskytuje Crossref.org
Gliadin peptides activate blood monocytes from patients with celiac disease